View links organized by who tweeted them or where they're pointing.

Some Favorite Sources: weei.com | boston.com | nytimes.com | washingtonpost.com | medium.com | theringer.com | espn.com | stonekettle.com | Current.org | niemanlab.org | hbr.org

Some Favorite Tweeters: @antrod | @benedictevans | @andrewchen | @bussgang | @cpricenfl | @techREDEF | @mediaREDEF | @sportsREDEF | @fashionREDEF | @mattermarkdaily | @jpbutler

Links Tweeted by: @biopharmadive

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 15, 2018 at 2:15 PM.

Recipharm to pay $60M for Sanofi manufacturing plant
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 15, 2018 at 1:47 PM.

Nonprofit pharma picks up coveted PRV
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 15, 2018 at 1:12 PM.

Lilly's Olumiant delivers positive Phase 2 lupus data
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 15, 2018 at 12:39 PM.

Bluebird's changes to LentiGlobin begin to pay off
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 15, 2018 at 12:08 PM.

Big pharma shows no signs of 'massive' drug price cuts
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 5:37 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 5:37 PM.

Sun Pharma gets reprieve as FDA clears key Halol plant
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 5:05 PM.

Sage licenses out depression drug in Asia, adding to cash warchest
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 4:38 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 4:12 PM.

Mylan preps for rejection of Advair copy
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 3:42 PM.

Big pharma shows no signs of 'massive' drug price cuts
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 1:51 PM.

GSK touts two-drug HIV therapy, intends to file this year
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 12:41 PM.

Mylan preps for rejection of Advair copy
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 14, 2018 at 12:06 PM.

Galmed stock jumps sky-high on mixed results for NASH drug
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, Jun 13, 2018 at 4:59 PM.

Eisai looking past amyloid, tau with new drug discovery center
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, Jun 13, 2018 at 4:28 PM.

Flex calling it quits after trial stop
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, Jun 13, 2018 at 12:49 PM.

BridgeBio launches new biotech to develop Alexion drug
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, Jun 12, 2018 at 1:47 PM.

Allergan's atogepant clears Phase 3 migraine test
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, Jun 12, 2018 at 1:22 PM.

Gene-editing biotechs drop as cancer concerns weigh on CRISPR
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, Jun 12, 2018 at 12:49 PM.

Lilly, AstraZeneca pull the plug on Alzheimer's trials
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, Jun 12, 2018 at 12:29 PM.

EMA moves forward with Amsterdam relocation
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Monday, Jun 11, 2018 at 1:39 PM.

Vical abandons herpes vaccine after mid-stage miss
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Monday, Jun 11, 2018 at 1:08 PM.

AbbVie, Roche win key US approval for blood cancer drug
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Monday, Jun 11, 2018 at 12:35 PM.

Sanofi partners with Translate Bio on mRNA vaccines
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Monday, Jun 11, 2018 at 12:03 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 6:05 PM.

Ipsen moves US headquarters to Cambridge
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 5:13 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 4:48 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 4:16 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 3:50 PM.

BIO18: FDA to issue guidance on cell and gene therapy in July
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 1:37 PM.

Advaxis lays off staff, refocuses cancer pipeline
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 1:10 PM.

Ipsen moves US headquarters to Cambridge
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 12:39 PM.

How Fujifilm became a contract manufacturer
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 12:14 PM.

Novo dips on job cuts report
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 8, 2018 at 11:42 AM.

ASCO18: Who were the big winners and losers?
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 7, 2018 at 3:30 PM.

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, Jun 7, 2018 at 2:54 PM.

BIO18: Merck's Ebola lessons; New Jersey vies for biotech jobs
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, Jun 6, 2018 at 11:32 AM.

AMA trumpets physician efforts in opioid epidemic fight
(healthcaredive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 1, 2018 at 1:57 PM.

Gilead's filgotinib clears mid-stage test in arthritis
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 1, 2018 at 1:24 PM.

Dova reveals $9K to $13.5K Doptelet price, stock sags
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 1, 2018 at 12:55 PM.

Ian M Stone on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, Jun 1, 2018 at 9:11 AM.

Allergan to sell off women's health, anti-infective businesses
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, May 31, 2018 at 1:52 PM.

Vertex, CRISPR gene-editing therapy hit with clinical hold
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, May 31, 2018 at 12:48 PM.

Madrigal scores in mid-stage NASH study
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Thursday, May 31, 2018 at 12:15 PM.

After a flurry, NASH deals put on pause
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 7:38 PM.

Half of orphan drug sales to come from cancer, Evaluate finds
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 7:07 PM.

Novo's oral semaglutide outperforms Jardiance in late-stage study
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 6:34 PM.

AstraZeneca won't submit lung drug for COPD after 2nd study miss
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 6:00 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 5:30 PM.

Allergan to sell off women's health, anti-infective businesses
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 5:04 PM.

Half of orphan drug sales to come from cancer, Evaluate finds
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 1:38 PM.

AstraZeneca won't submit lung drug for COPD after 2nd study miss
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 12:43 PM.

Novo's oral semaglutide outperforms Jardiance in late-stage study
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 12:15 PM.

TherapeuticsMD garners FDA OK for Imvexxy
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Wednesday, May 30, 2018 at 12:09 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, May 29, 2018 at 4:14 PM.

Genmab stumbles after J&J dumps Darzalex combo trial
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, May 29, 2018 at 4:11 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, May 29, 2018 at 3:39 PM.

BioPharma Dive on Twitter
(twitter.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, May 29, 2018 at 3:10 PM.

Pharma turn to NASH unlikely to mirror meteoric rise of hep C
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, May 29, 2018 at 1:45 PM.

From the ashes, Axovant proves its recruiting skills are still top-notch
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, May 29, 2018 at 12:33 PM.

Tecentriq trial wins boost Roche bid to compete with Merck
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Tuesday, May 29, 2018 at 12:00 PM.

Genmab hits roadblock in non-Hodgkin lymphoma
(biopharmadive.com)
Tweeted out by BioPharma Dive, @BioPharmaDive, on Friday, May 25, 2018 at 2:23 PM.

© Serendeputy 2011-2017. Email: jason / serendeputy.com